In studies included in this meta- analysis , probiotic administration was associated with a reduction in NEC-related mortality
Aim of the study Probiotic administration to preterm infants has the potential to prevent necrotising enterocolitis ( NEC ) .
Data from r and omised controlled trials ( RCT ) are conflicting but meta-analyses seem to support this intervention .
To date , these analyses have not focused on surgical NEC .
We aim ed to determine the effect of probiotic administration  to preterm infants on prevention of surgical NEC .
Effect of Bifidobacterium lactis on the Incidence of Nosocomial Infections in Very-Low-Birth-Weight Infants: A Randomized Controlled Trial
Background : Nosocomial infections endanger preterm infants . Objective : The aim of the present controlled r and omized trial was to investigate whether Bifidobacterium lactis reduces the incidence of nosocomial infections in infants with very low birth weight ( VLBW ; < 1,500 g ) < 30 weeks of gestation . Patients and Methods : In a r and omized controlled trial , 183 VLBW infants < 30 weeks of gestation were stratified according to gestational age ( 23–26 and 27–29 weeks ) and early antibiotic therapy ( days 1–3 , yes or no ) and r and omly assigned to have their milk feedings supplemented with B. lactis ( 6 × 2.0 × 109 CFU/kg/day , 12 billion CFU/kg/day ) or placebo for the first 6 weeks of life . Primary outcome was the ‘ incidence density ’ of nosocomial infections defined as periods of elevated C-reactive protein ( > 10 mg/l ) from day 7 after initiation of milk feedings until the 42nd day of life ( number of nosocomial infections/total number of patient days ) . The main secondary outcome was necrotizing enterocolitis ( NEC ; ≧stage 2 ) . Results : There were 93 infants in the B. lactis group and 90 in the placebo group . There was no significant difference between the two groups with regard to the incidence density of nosocomial infections ( 0.021 vs. 0.016 ; p = 0.9 , χ2 test ) . There were 2 cases of NEC in the B. lactis group and 4 in the placebo group . None of the blood cultures grew B. lactis . Conclusion : In the present setting , B. lactis at a dosage of 6 × 2.0 × 109 CFU/kg/day ( 12 billion CFU/kg/day ) did not reduce the incidence density of nosocomial infections in VLBW infants . No adverse effect of B. lactis was observed
In studies included in this meta- analysis , probiotic administration was associated with a reduction in NEC-related mortality
Aim of the study Probiotic administration to preterm infants has the potential to prevent necrotising enterocolitis ( NEC ) .
Data from r and omised controlled trials ( RCT ) are conflicting but meta-analyses seem to support this intervention .
To date , these analyses have not focused on surgical NEC .
We aim ed to determine the effect of probiotic administration  to preterm infants on prevention of surgical NEC .